CTBP1 and lung carcinoma: Nicotine is known to be able to bind to β-ARs and can also trigger the production of β-AR ligands, such as adrenaline and noradrenaline, leading to activating β-ARs, promoting cancer progression and inhibiting apoptosis induced by cisplatin in lung cancer cells [7,8,14,65].